RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 125 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $53,301 | +56.8% | 35,534 | +22.2% | 0.00% | – |
| Q3 2022 | $34,000 | -26.1% | 29,086 | +87.8% | 0.00% | – |
| Q1 2022 | $46,000 | +76.9% | 15,487 | +34.5% | 0.00% | – |
| Q4 2018 | $26,000 | -89.1% | 11,515 | -83.0% | 0.00% | -100.0% |
| Q1 2018 | $239,000 | +368.6% | 67,550 | +236.1% | 0.00% | – |
| Q3 2017 | $51,000 | -96.3% | 20,100 | -94.6% | 0.00% | -100.0% |
| Q3 2016 | $1,376,000 | +3100.0% | 375,000 | +1842.6% | 0.01% | – |
| Q2 2016 | $43,000 | -46.2% | 19,304 | -49.8% | 0.00% | – |
| Q1 2016 | $80,000 | +73.9% | 38,464 | +151.0% | 0.00% | – |
| Q4 2015 | $46,000 | -68.3% | 15,324 | -76.0% | 0.00% | -100.0% |
| Q4 2014 | $145,000 | -87.9% | 63,773 | -89.7% | 0.00% | -88.9% |
| Q3 2014 | $1,203,000 | -68.5% | 620,000 | -53.7% | 0.01% | -82.0% |
| Q4 2013 | $3,813,000 | +7.2% | 1,338,036 | +34.6% | 0.05% | +4.2% |
| Q3 2013 | $3,558,000 | +77.6% | 993,740 | +65.7% | 0.05% | +41.2% |
| Q2 2013 | $2,003,000 | – | 599,711 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 4,500,000 | $11,925,000 | 4.90% |
| HealthInvest Partners AB | 1,090,000 | $2,889,000 | 4.07% |
| GREAT POINT PARTNERS LLC | 5,000,000 | $13,250,000 | 2.94% |
| CM Management, LLC | 775,000 | $2,054,000 | 1.55% |
| SECTOR GAMMA AS | 1,469,604 | $3,894,000 | 0.92% |
| Sio Capital Management, LLC | 913,621 | $2,421,000 | 0.73% |
| Telemetry Investments, L.L.C. | 190,000 | $504,000 | 0.65% |
| DAFNA Capital Management LLC | 879,000 | $2,329,000 | 0.59% |
| Rock Springs Capital Management LP | 4,860,200 | $12,880,000 | 0.30% |
| Rhenman & Partners Asset Management AB | 1,520,000 | $4,074,000 | 0.27% |